CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells

CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells

Abstract Introduction Radioresistance is a major challenge in lung cancer radiotherapy, and new radiosensitizers are urgently needed. Estrogen receptor β (ERβ) is involved in the progression of non-small cell lung cancer (NSCLC), however, the role of ERβ in the response to radiotherapy in lung cance...

Full description

Bibliographic Details
Main Authors: Hang Li, Jun Che, Mian Jiang, Ming Cui, Guoxing Feng, Jiali Dong, Shuqin Zhang, Lu Lu, Weili Liu, Saijun Fan
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Cell Communication and Signaling
Subjects:
Radioresistance
Non-small cell lung cancer
CLPTM1L
ERβ
Radiotherapy
Online Access:http://link.springer.com/article/10.1186/s12964-020-00571-4

Internet

http://link.springer.com/article/10.1186/s12964-020-00571-4

Similar Items